<?xml version="1.0" encoding="UTF-8"?>
<ref id="B71-biomedicines-08-00060">
 <label>71.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chen</surname>
    <given-names>C.-Y.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>P.-Y.</given-names>
   </name>
   <name>
    <surname>Hutzen</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Sprague</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Swain</surname>
    <given-names>H.M.</given-names>
   </name>
   <name>
    <surname>Love</surname>
    <given-names>J.K.</given-names>
   </name>
   <name>
    <surname>Stanek</surname>
    <given-names>J.R.</given-names>
   </name>
   <name>
    <surname>Boon</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Conner</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Cripe</surname>
    <given-names>T.P.</given-names>
   </name>
  </person-group>
  <article-title>Cooperation of oncolytic herpes virotherapy and PD-1 blockade in murine rhabdomyosarcoma models</article-title>
  <source>Sci. Rep.</source>
  <year>2017</year>
  <volume>7</volume>
  <fpage>2396</fpage>
  <pub-id pub-id-type="doi">10.1038/s41598-017-02503-8</pub-id>
  <pub-id pub-id-type="pmid">28539588</pub-id>
 </element-citation>
</ref>
